Arama

EISSN 2475-0581

IMPACT FACTOR: 0.7 INDEXED IN WEB OF SCIENCE

Psychiatry and Clinical Psychopharmacology

PDF

HIGHLY CITED ARTICLES

The Effect of COVID-19 Pandemic on Psychosomatic Complaints and Investigation of The Mediating Role of Intolerance to Uncertainty, Biological Rhythm Changes and Perceived COVID-19 Threat in this Relationship: A Web-Based Community Survey

by Gıca et al.

COVID-19 Vaccine Hesitancy and Its Relationship With Illness Risk Perceptions, Affect, Worry, and Public Trust: An Online Serial Cross-Sectional Survey From Turkey

by Kucukkarapinar et al.

Evaluation of the Psychiatric Research Output From Turkey Via Web of Science Database: A Bibliometric Analysis

by Topal et al.

High Doses of Second-Generation Long-Acting Antipsychotics in the Treatment of Patients with Severe Resistant Schizophrenia: A Six-Year Mirror-Image Study

by Fernandez- Miranda et al.

Video/Computer Game Addiction Among University Students in Ghana: Prevalence, Correlates and Effects of Some Demographic Factors

by Miezah et al.

Burnout, Job Satisfaction, and Psychological Symptoms Among Emergency Physicians During COVID-19 Outbreak: A Cross-Sectional Study

by Bahadırlı and Sağaltıcı.

Parental Attachment and the Theory of Mind Abilities as Predictors of Internet Addiction in Turkish Adolescents

by Akdeniz et al.

Investigating the Impact of the ECT on Thiol-Disulphide Homeostasis in Depressive Disorders

by Atagün et al.

Comparison of Drugs Prescribed by Psychiatrists and Child/Adolescent Psychiatrists

by Aydin et al.

Adaptation of Internet Gaming Cognition Scale to Turkish: Reliability and Validity Study

by Cakiroglu and Soylu.

All Title Keyword Full Text DOI

Authors

Article Type

Article Category

Year

Search Results

Total of 20 results

Ranking

Release Date Sort Sort Article Type

Prevalence of metabolic syndrome in patients of a community mental health center

Kader Karatas

( Psychiatry and Clinical Psychopharmacology 2015; 25: S178-S179)

Abstract Full Text ( PDF) Related Articles

Relationship between metabolic syndrome and panic disorder

Yasemin Kaya, Esra Yancar, Havva Keskin, Ahmet Kaya

( Psychiatry and Clinical Psychopharmacology 2015; 25: S176-S176)

Abstract Full Text ( PDF) Related Articles

Serum peroxisome proliferator-activated receptor-gamma levels in acute phase of male patients with schizophrenia and their relationship with metabolic parameters

Tevfik Kalelioglu, Nurdan Durak, Nesrin Karamustafalioglu, Abdullah Genc, Mustafa Akkus, Akif Tasdemir, Cem Ilnem

( Psychiatry and Clinical Psychopharmacology 2017; 27: 30-34) DOI: 10.1080/24750573.2017.1293244

Abstract Full Text ( PDF) Related Articles

Prevalence of metabolic syndrome in patients of a community mental health center

Relationship between metabolic syndrome and panic disorder

Serum peroxisome proliferator-activated receptor-gamma levels in acute phase of male patients with schizophrenia and their relationship with metabolic parameters

The prevalence of metabolic syndrome in outpatients with severe mental illness in antipsychotic monotherapy or polypharmacy

Vitamin D level in schizophrenia and association with metabolic syndrome parameters

Cardiometabolic risk in Turkish patients with first episode schizophrenia

Cardiovascular risk and metabolic syndrome in Turkish patients with chronic schizophrenia

Prevalence of metabolic syndrome in patients who are recorded in Corum Community Mental Health Center with the diagnosis of psychotic disorders

Treat the patient, not the illness: excessive weight gain with quetiapine and weight loss with olanzapine

The prevalence of metabolic syndrome parameters among bipolar disorder outpatients on lithium monotherapy

Metabolic syndrome and depressive symptoms in a primary health care setting in Turkey

Frequency of metabolic syndrome in obsessive compulsive disorder patients on antidepressant monotherapy vs antidepressant plus atypical antipsychotic combination therapy: a naturalistic, descriptive pilot study

The relationship of metabolic syndrome, serum leptin levels and treatment in bipolar disorder

Metabolic syndrome

Schizophrenia and diabetes mellitus: Diabetes mellitus or metabolic syndrome caused by new generation antipsychotics

Metabolic side effects of new generation antipsychotics

Psychopharmacology The factors related to the development or reversal of metabolic syndrome in the patients schizophrenia and schizoaffective disorder: a naturalistic follow-up

Psychopharmacology Antipsychotics and metabolic syndrome: a naturalistic six-month follow-up study

Clinical psychiatry The frequency of metabolic syndrome in psychiatric patients taking antidepressant medication

The relationship between the serum bilirubin levels and metabolic syndrome in schizophrenia patients